Patient Reported Outcomes Validity and Valuation
Patient Engagement is More Than a Catchphrase: One Patient Does Not Engagement Make
Understanding the Results of SGLT2 Inhibitors Heart Failure Trials
Evidence Generation in Food and Diet Health Science: Parts 1 and 2
How will the removal of requirement for CVOTs from FDA shape the future of trial design?
Operational Shifts in Trial Conduct: Lessons Learnt From The COVID-19 Crisis
CVCT-WOMEN AS ONE : Evidence Gaps in Women's CV Health and How to Improve Women's Leadership
Understanding and Interpreting the Results of Mineralocorticoid Receptor Antagonists Trials
FIDELIO Trial in Context
The Value of Biomarkers in Trials
NASH and Obesity Trials: Parts 1 and 2
The Transformation of Trial Conduct Post-COVID. How to Keep the Best?
How Will the HFrEF Therapy Landscape Change?
Electrophysiology: Parts 1 and 2
SGLT2i: Trials in CKD
Data Science and Information Technology Revolutionizing Clinical Trials